A Win For Diffusion Pharmaceuticals Inc.
Tue, May 18, 2021 at 05:30 PM
Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ) rocketted at $0.75, a gain of 21%. On Mon, May 17, 2021, DFFN:NASDAQ touched a New 2-Week Intraday Low of $0.6. The stock appeared on our News Catalysts scanner on Fri, May 14, 2021 at 01:26 PM in the 'BIOTECH' category. From Mon, May 03, 2021, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Feb 17, 2021 at $1.85 with a volume of 32M+, and its share price has been moving sideways in recent weeks.
About Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ)
Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.
Top 10 Gainers:
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 75.04%
- Landcadia Holdings II, Inc. (LCA:NASDAQ), 64.56%
- BMTX (BMTX:NYSEMKT), 26.42%
- Predictive Oncology Inc. (POAI:NASDAQ), 26.03%
- Ultralife Corporation (ULBI:NASDAQ), 23.38%
- Medley LLC SR NT 26 (MDLX:NYSE), 22.18%
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 22.03%
- Moxian, Inc. (MOXC:NASDAQ), 21.02%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 21%
- Aemetis, Inc. (AMTX:NASDAQ), 20.94%